“The Future of Healing™” is a core driver behind the founding of Luminec Animal Sciences Corp. Devoted to developing and commercializing revolutionary animal health care solutions through the application of innovative molecular technology, Luminec collaborates with a variety of veterinary academic institutions, practicing veterinarians, and is led by a board of distinguished animal health industry experts. The company’s unique mix of medicinal chemistry, molecular engineering, and innovative product manufacturing capabilities positions it to deliver truly cutting-edge animal health care solutions.
Luminec’s technology is based on the Free Amino Ion Theory of Cell Stabilization, delivered through Triamino™ and Triamino Fulvate™ molecules. These miracle molecules release free amino ions which by the process of biosynthesis, stabilize troubled cells, and facilitates those cells to return to healthy function. This has been shown through veterinary testing in the animal health care industry since 2000. Recent partnerships have yielded even more efficacious treatment results with the development of an outstanding class of Triamino and Fulvic Acid molecule combinations. These continued treatment discovery efforts, combined with the industry experience of the executive management team and the advisory board, promise a full and sustainable product pipeline.
U.S. Product Pipeline
At Luminec, we’re leveraging innovative molecular technologies to develop products designed specifically for companion pets, horses, and livestock. Our first efficacy-candidates utilizing the Triamino and Triamino Fulvate™ molecules were branded as TAFA400™ treatments and launched in Q1 2011.
For more information relating to Luminec’s product pipeline and partnering opportunities, click here.
For more information relating to Luminec Animal Sciences Corp.’s Private Placement Memorandum and investing opportunities, click here.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
The information provided on this site includes forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are subject to a variety of risks and uncertainties and reflect Luminec’s current views with respect to future events and financial performance. You can identify forward-looking statements by the use of the words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “will,” “should” and other expressions which predict or indicate future events and trends and which do not relate to historical matters. You should not rely on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, some of which are beyond the control of the Company. These risks, uncertainties and other factors may cause the actual results, performance or achievements of the Company to be materially different from the anticipated future results, performance or achievements expressed or implied by the forward-looking statements.